comparemela.com

Latest Breaking News On - Nicolas fellmann - Page 4 : comparemela.com

Biophytis Announces New Scientific Advisory Board for its Phase 2 OBA Clinical Study in Obesity

Biophytis SA (Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specialized in the development of therapeutics for age-related diseases, today announces the formation of a new.

Biophytis launches OBA phase 2 clinical study in obesity with BIO101 (20-hydroxyecdysone)

Biophytis launches OBA phase 2 clinical study in obesity with BIO101 (20-hydroxyecdysone)
tennesseedaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tennesseedaily.com Daily Mail and Mail on Sunday newspapers.

Biophytis Announces Its 2023 Financial Results and Provides an Update on Its Business Activities

Biophytis Announces Its 2023 Financial Results and Provides an Update on Its Business Activities
tennesseedaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tennesseedaily.com Daily Mail and Mail on Sunday newspapers.

Results of the Combined General Meeting on April 2, 2024

Results of the Combined General Meeting on April 2, 2024
tennesseedaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tennesseedaily.com Daily Mail and Mail on Sunday newspapers.

Biophytis announces its 2023 financial results and provides an update on its business activities

Biophytis / Key word(s): Annual ResultsBiophytis announces its 2023 financial results and provides an update on its business activities 08-Apr-2024 / 23:01 CET/CESTBiophytis announces its 2023 financial results and provides an update on its business activities  Paris (France) and Cambridge (Massachusetts, USA.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.